The company offers year-round educational services on the conditions, using this month in particular to guide patients to ...

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

Editor's note: The below transcript has been lightly edited for clarity. Ramiro Ribeiro, MD, PhD: Sure So at Hawaiian Eye, we gave an update on our phase 2 program, the Davio-2 study, that is the ...

Panelists discuss how faricimab’s dual inhibition of Ang-2 provides additional benefits in vascular stability and inflammation reduction beyond VEGF-A suppression alone, potentially leading to ...

Panelists discuss how both medications demonstrate favorable safety profiles in clinical trials, with aflibercept 8 mg benefiting from extensive 2-mg safety data, while acknowledging the need to ...

Korean investigators reported that faricimab (Vabysmo, Roche/Genentech) in a real-world setting works well for patients with neovascular age-related macular degeneration (nAMD) refractory to other ...

Ashkan Abbey, MD, shares insights from the one-year data for the phase 2 DAVIO2 trial and the impact of tyrosine kinase inhibitors on reducing treatment burden. Basically, we were looking at the ...

Panelists discuss how the potential availability of tyrosine kinase inhibitors (TKIs) could diminish some advantages of the PDS system, as oral medications would provide an alternative approach to ...

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

A large study that retrospectively analyzed the visual outcomes and rate of development of neovascular age-related macular degeneration (nAMD) in eyes with geographic atrophy (GA) found that GA can ...

The Sentinel Camera aims to address critical gaps in retinal disease screening by offering a portable device that captures high-quality images that require no dilation of the eye. AI Optics, an ...